Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Non-Current Deferred Tax Liability (2016 - 2020)

Historic Non-Current Deferred Tax Liability for Summit Therapeutics (SMMT) over the last 5 years, with Q3 2020 value amounting to $2.1 million.

  • Summit Therapeutics' Non-Current Deferred Tax Liability changed N/A to $2.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2019, which is N/A changed from last year.
  • Latest data reveals that Summit Therapeutics reported Non-Current Deferred Tax Liability of $2.1 million as of Q3 2020.
  • Summit Therapeutics' 5-year Non-Current Deferred Tax Liability high stood at $2.1 million for Q3 2020, and its period low was -$3.4 million during Q1 2018.
  • For the 5-year period, Summit Therapeutics' Non-Current Deferred Tax Liability averaged around -$1.4 million, with its median value being -$2.0 million (2019).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first plummeted by 58140.99% in 2018, then soared by 3639.81% in 2019.
  • Summit Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at -$811000.0 in 2016, then grew by 7.52% to -$750000.0 in 2017, then crashed by 195.38% to -$2.2 million in 2018, then increased by 9.46% to -$2.0 million in 2019, then soared by 205.1% to $2.1 million in 2020.
  • Its last three reported values are $2.1 million in Q3 2020, -$2.2 million for Q1 2020, and -$2.0 million during Q4 2019.